605177 東亞藥業
按盤價 
20.440 +1.840 (+9.892%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.615 | 6.290 | 5.805 | 3.928 | 8.883 |
| 總資產報酬率 ROA (%) | 0.974 | 4.170 | 4.422 | 3.162 | 7.182 |
| 投入資產回報率 ROIC (%) | 1.118 | 4.781 | 5.098 | 3.600 | 8.427 | 邊際利潤分析 |
| 銷售毛利率 (%) | 25.811 | 26.640 | 22.818 | 28.229 | 33.969 |
| 營業利潤率 (%) | 6.526 | 10.098 | 10.224 | 11.081 | 15.172 |
| 息稅前利潤/營業總收入 (%) | 5.721 | 9.347 | 8.542 | 7.996 | 14.631 |
| 淨利潤/營業總收入 (%) | 5.008 | 8.939 | 8.853 | 9.617 | 12.985 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 85.697 | 93.957 | 90.003 | 76.019 | 92.836 |
| 價值變動淨收益/利潤總額(%) | 7.329 | 5.218 | 6.823 | 9.625 | 0.000 |
| 營業外收支淨額/利潤總額(%) | -8.011 | -1.692 | -4.778 | -2.416 | -2.750 | 償債能力分析 |
| 流動比率 (X) | 2.798 | 2.503 | 2.087 | 2.610 | 4.412 |
| 速動比率 (X) | 1.586 | 1.613 | 1.239 | 1.676 | 3.559 |
| 資產負債率 (%) | 39.682 | 39.723 | 25.567 | 21.900 | 16.902 |
| 帶息債務/全部投入資本 (%) | 26.482 | 30.232 | 10.435 | 9.441 | 2.641 |
| 股東權益/帶息債務 (%) | 266.385 | 224.801 | 836.847 | 935.986 | 3,606.761 |
| 股東權益/負債合計 (%) | 151.999 | 151.744 | 291.124 | 356.616 | 491.646 |
| 利息保障倍數 (X) | -17.819 | -16.028 | -7.030 | -2.832 | -108.522 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 43.445 | 31.747 | 26.967 | 44.494 | 36.213 |
| 存貨周轉天數 (天) | 245.577 | 199.681 | 178.371 | 241.874 | 172.330 |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
